Table 3.
Cancer type | Age at diagnosis in offspring | Genetic markers of maternal cells | Reference | |
---|---|---|---|---|
Leukaemia/lymphoma: | ||||
1. | Lymphosarcoma | birth | [98] | |
2. | Hodgkin’s disease | 3 weeks | [99] | |
3. | NK cell lymphoma | 4 weeks | t(X; 11), XX | [45] |
4. | AML | 20 months | XX | [50] |
5. | ALL | 9 months | [100] | |
6. | ALL | 5 months | Karyotype | [101] |
7. | B cell lymphoma | 8 months | XX | [37] |
8. | ALL | 11 months | Micro-satellite markers + BCR-ABL1 sequence | [35] |
9. | NK/T lymphoma | 8 months | Micro-satellite markers | [36] |
Melanoma: | ||||
10. | 8 months | [102] | ||
11. | 11 days | [103] | ||
12. | 7 weeks | [104] | ||
13. | 7 months | [105] | ||
14. | 2 months | [51] | ||
15. | birth | [40] | ||
16. | birth | [32] | ||
17. | 7 months | XX | [106] | |
18. | 6 months | [38] | ||
19. | 3 months | [42] | ||
20. | Lung adenocarcinoma | 2 weeks | XX | [44] |
21. | SCLC | 5 months | XX | [107] |
22. | SCLC | 5 months | [39] | |
23. | Lung adenocarcinoma | 2 months | [108] | |
24. | Neuro-endocrine cervical ca. | 8 months | [41] | |
25. | Breast ca. | 14 months | [43] | |
26. | Hepatic ca. | birth | [32] |